Annual CFI
-$1.77B$629.18M+26.17%
Summary
- Current Value
- As of today, GSK annual cash from investing is -$1.77B, up +26.17% on
- Historical Performance
- GSK annual cash from investing is up +28.02% over the past 3 years, and up +74.47% over the past 5 years
- All-Time High Comparison
- GSK annual cash from investing is currently -119.58% below its historical high of $9.06B set on
- 3-Year Low Comparison
- GSK annual cash from investing is +83.69% above its 3-year low of -$10.88B reached on an earlier date
- Sector Comparison
- GSK annual cash from investing is higher than 2.88% of companies in Healthcare sector
Cash From Investing Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash From Investing | -$1.77B | +26.2% | +28.0% | +74.5% | +72.5% | |
| Quarterly Cash From Investing | -$2.15B | -125.7% | +57.1% | -199.8% | -175.7% | |
| TTM Cash From Investing | -$6.06B | -10000.0% | +44.3% | -361.7% | -84.2% | |
| Price | $50.22 | +48.8% | +43.8% | +28.5% | +27.1% | |
| Annual Cash From Operations | $7.78B | -1.4% | -21.4% | -15.4% | -30.8% | |
| Annual Cash From Financing | -$5.24B | +13.6% | +44.1% | -338.1% | -67.5% | |
| Annual CAPEX | $3.81B | +30.8% | +4.4% | +38.1% | +29.6% | |
| Annual Free Cash Flow | $3.97B | -20.2% | -36.5% | -38.4% | -52.2% | |
| Annual Total Assets | $74.47B | -1.0% | -30.5% | -29.5% | +7.6% |
Cash From Investing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$1.77B | at high | |
| 5Y | $2.69B | N/A | -166.1% |
| All | $9.06B | -119.6% |
Cash From Investing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$10.88B | N/A | +83.7% |
| 5Y | -$10.88B | +83.7% | |
| All | -$14.62B | +87.9% |
Cash From Investing History
FAQ
What is the current annual cash from investing of GSK?
As of today, GSK annual cash from investing is -$1.77B
What is 1-year change in GSK annual cash from investing?
GSK annual cash from investing is up +26.17% year-over-year
What is 3-year change in GSK annual cash from investing?
GSK annual cash from investing is up +28.02% over the past 3 years
How far is GSK annual cash from investing from its all-time high?
GSK annual cash from investing is currently -119.58% below its historical high of $9.06B set on December 31, 2015
How does GSK annual cash from investing rank versus sector peers?
GSK annual cash from investing is higher than 2.88% of companies in Healthcare sector
When is GSK next annual earnings release?
The next annual earnings release for GSK is on
Quarterly CFI
-$2.15B$1.33B-160.63%
Summary
- Current Value
- As of today, GSK quarterly cash from investing is -$2.15B, down -160.63% on
- Historical Performance
- GSK quarterly cash from investing is down -125.71% year-over-year, and up +57.06% over the past 3 years
- All-Time High Comparison
- GSK quarterly cash from investing is currently -120.16% below its historical high of $10.66B set on
- 3-Year Low Comparison
- GSK quarterly cash from investing is at its 3-year low
- Sector Comparison
- GSK quarterly cash from investing is higher than 0.73% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash From Investing | -$2.15B | -160.6% | -125.7% | +57.1% | -199.8% | |
| Annual Cash From Investing | -$1.77B | – | +26.2% | +28.0% | +74.5% | |
| TTM Cash From Investing | -$6.06B | -24.6% | -10000.0% | +44.3% | -361.7% | |
| Price | $50.22 | +15.8% | +48.8% | +43.8% | +28.5% | |
| Quarterly Cash From Operations | $3.03B | +22.8% | +11.2% | +108.8% | +192.9% | |
| Quarterly Cash From Financing | -$1.71B | +38.5% | -10.9% | +2.3% | +67.9% | |
| Quarterly CAPEX | $1.20B | +44.4% | +12.2% | +114.3% | +47.9% | |
| Quarterly Free Cash Flow | $1.82B | +11.7% | +10.5% | +105.2% | +726.9% | |
| Quarterly Total Assets | $82.58B | +1.7% | +6.0% | +22.6% | -21.1% |
Quarterly Cash From Investing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$824.98M | -160.6% | |
| 3Y | $924.65M | -332.5% | |
| 5Y | $924.65M | -332.5% | |
| All | $10.66B | -120.2% |
Quarterly Cash From Investing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$2.15B | at low | |
| 3Y | -$2.15B | at low | |
| 5Y | -$5.01B | +57.1% | |
| All | -$13.29B | +83.8% |
Quarterly Cash From Investing History
FAQ
What is the current quarterly cash from investing of GSK?
As of today, GSK quarterly cash from investing is -$2.15B
What is GSK quarterly cash from investing most recent change?
GSK quarterly cash from investing was down -160.63% on September 1, 2025
What is 1-year change in GSK quarterly cash from investing?
GSK quarterly cash from investing is down -125.71% year-over-year
How far is GSK quarterly cash from investing from its all-time high?
GSK quarterly cash from investing is currently -120.16% below its historical high of $10.66B set on March 31, 2015
How does GSK quarterly cash from investing rank versus sector peers?
GSK quarterly cash from investing is higher than 0.73% of companies in Healthcare sector
When is GSK next earnings release?
The next earnings release for GSK is on
TTM CFI
-$6.06B$1.20B-24.60%
Summary
- Current Value
- As of today, GSK TTM cash from investing is -$6.06B, down -24.60% on
- Historical Performance
- GSK TTM cash from investing is down -64895.93% year-over-year, and up +44.26% over the past 3 years
- All-Time High Comparison
- GSK TTM cash from investing is currently -165.00% below its historical high of $9.33B set on
- 3-Year Low Comparison
- GSK TTM cash from investing is +43.81% above its 3-year low of -$10.79B reached on an earlier date
- Sector Comparison
- GSK TTM cash from investing is higher than 0.64% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM Cash From Investing | -$6.06B | -24.6% | -10000.0% | +44.3% | -361.7% | |
| Annual Cash From Investing | -$1.77B | – | +26.2% | +28.0% | +74.5% | |
| Quarterly Cash From Investing | -$2.15B | -160.6% | -125.7% | +57.1% | -199.8% | |
| Price | $50.22 | +15.8% | +48.8% | +43.8% | +28.5% | |
| TTM Cash From Operations | $9.75B | +3.2% | +12.8% | -11.8% | +7.8% | |
| TTM Cash From Financing | -$4.09B | -4.3% | +52.0% | -10000.0% | +67.1% | |
| TTM CAPEX | $4.11B | +3.3% | +25.0% | +57.1% | +52.4% | |
| TTM Free Cash Flow | $5.64B | +3.2% | +5.3% | -33.1% | -11.1% | |
| Quarterly Total Assets | $82.58B | +1.7% | +6.0% | +22.6% | -21.1% |
TTM Cash From Investing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$1.79B | N/A | -238.4% |
| 3Y | $292.30M | -2174.9% | |
| 5Y | $2.73B | -322.4% | |
| All | $9.33B | -165.0% |
TTM Cash From Investing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$6.06B | at low | |
| 3Y | -$10.79B | N/A | +43.8% |
| 5Y | -$10.88B | +44.3% | |
| All | -$19.30B | +68.6% |
TTM Cash From Investing History
FAQ
What is the current TTM cash from investing of GSK?
As of today, GSK TTM cash from investing is -$6.06B
What is GSK TTM cash from investing most recent change?
GSK TTM cash from investing was down -24.60% on September 1, 2025
What is 1-year change in GSK TTM cash from investing?
GSK TTM cash from investing is down -64895.93% year-over-year
How far is GSK TTM cash from investing from its all-time high?
GSK TTM cash from investing is currently -165.00% below its historical high of $9.33B set on March 31, 2015
How does GSK TTM cash from investing rank versus sector peers?
GSK TTM cash from investing is higher than 0.64% of companies in Healthcare sector
When is GSK next earnings release?
The next earnings release for GSK is on
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
Data Sources & References
- GSK Official Website www.gsk.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1131399/000113139925000007/0001131399-25-000007-index.htm
- GSK Profile on Yahoo Finance finance.yahoo.com/quote/GSK
- GSK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gsk